TFCT NIB GRAPE FLV (Tofacitinib (1.62mg))

Tfct-Nib Oral Solution is indicated for the management of moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication works by alleviating pain, inflammation, and swelling in the joints, consequently reducing discomfort and enhancing mobility. It also plays a role in slowing down potential damage to bones and joints associated with these conditions. Tfct-Nib may be administered alone or in conjunction with other medications, and it can be taken with or without food; however, it is advisable to take it consistently at the same time each day. The specific dosage prescribed will be determined by your medical condition and any concurrent medications you may be using. It is essential to adhere to your healthcare provider’s instructions regarding the use of this medicine, and you should not discontinue it without professional guidance, as this could lead to a deterioration of your condition. Prior to starting this treatment, you might require blood tests, and it is crucial to avoid initiating therapy if there is an existing infection. Discuss with your doctor if you have a history of tuberculosis, shingles, kidney or liver disorders, hepatitis B or C, or have experienced blood clots in the legs or lungs. This medication may increase your susceptibility to infections or exacerbate any existing infections, so it is advisable to steer clear of individuals who have contagious illnesses like chickenpox, measles, or the flu. Tfct-Nib is not recommended for individuals under 18 years of age and its use during pregnancy or breastfeeding should only occur if the benefits are deemed to outweigh the risks by your healthcare provider. Regular monitoring by your doctor may be necessary during treatment.